Justin W. Yorke - Jun 27, 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Jun 27, 2023
Transactions value $
$0
Form type
4
Date filed
7/24/2023, 06:35 PM
Previous filing
May 15, 2023
Next filing
Oct 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +23.6K +71.42% 56.7K Jun 27, 2023 Direct F1
holding PCSA Common Stock 520K Jun 27, 2023 By Richland Fund, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Options Exercise $0 -23.6K -100% $0.00* 0 Jun 27, 2023 Common Stock 23.6K $0.00 Direct F1
transaction PCSA Restricted Stock Award $0 +101K $0.00 101K Jun 27, 2023 Common Stock 101K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.